Exponent, Inc. (EXPO)

In the past six months, Exponent, Inc.'s stock price has declined, with the share price at $69.31 as of October 24, 2025, a 29.13% decrease from $97.80 on October 28, 2024. Insider selling by key executives and directors has been noted between May and October 2025. In Q2 CY2025, Exponent reported revenues of $142 million, exceeding market expectations, with a 7.2% year-on-year growth, but Q3 CY2025 revenue guidance was less impressive at $131.3 million, falling below analysts' estimates. The company's GAAP profit of $0.52 per share beat analyst estimates by 5.6%, but the operating margin declined to 12.1% from 27% in the same quarter last year, contributing to lower earnings per share. UBS adjusted its price target on Exponent to $76 from $84 in August 2025, while maintaining a "Neutral" rating.

No specific information regarding demand seasonality for Exponent, Inc.'s products and services was found in the provided search results.

Exponent, Inc. is a leading engineering and scientific consulting firm providing solutions to complex problems across various industries, operating within the Industrials sector, specifically in Business Support Services. Its core business is rooted in failure and accident analysis, and it offers a wide range of consulting services through two primary segments: Engineering and Other Scientific, and Environmental and Health. These services encompass over 90 technical disciplines, addressing challenges in industries such as chemicals, construction, consumer products, and more, throughout the complete product or process lifecycle.

Exponent, Inc. is headquartered in Menlo Park, California, and has a global geographic footprint with offices located across North America, Europe, and Asia.

Exponent has demonstrated its expertise and commitment to addressing critical scientific and regulatory challenges, publishing content regarding "Navigating CARB's Climate Disclosure Regulations" and sponsoring the 2021 Prop 65 Conference. While the stock price decline and insider selling might be perceived negatively by investors, there is no direct information indicating a negative impact on the company's brand reputation in terms of its scientific and engineering consulting services.

Exponent, Inc. is predominantly owned by institutional shareholders, who hold 96.44% of the company, while individual insiders own 2.54%, and retail investors hold 1.01%. Major institutional owners include BlackRock, Inc., Vanguard Group Inc, and Kayne Anderson Rudnick Investment Management Llc, among others.